FDA / 2026

Wegovy application and labeling record

Wegovy application and labeling record — U.S. FDA (2026), cited in PeptideAgent's Semaglutide evidence record.

Open original source

SOURCE METADATA

What this record represents.

Publisher
U.S. FDA
Evidence type
FDA
Publication year
2026
Source ID
fda-wegovy

WHERE THIS IS CITED

Connected evidence records.

SemaglutidePeptide analog · Weight & Metabolism